Marshall Wace North America’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Marshall Wace North America’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-46,933	Closed	-$1.76M	–	1910
2018 Q1	$1.76M	Buy	+46,933	New	+$1.97M	0.01%	844

Marshall Wace North America's ARMO Position: Q2 2018 in Review

Marshall Wace North America sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 46,933 shares — an estimated $1.76M sold.

Marshall Wace North America first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $1.76M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Marshall Wace North America reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Marshall Wace North America sold 46,933 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $1.76M.
Marshall Wace North America first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Marshall Wace North America's ARMO BioSciences, Inc. Common Stock position peaked at $1.76M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.